Literature DB >> 2559518

GABAB receptors and their significance in mammalian pharmacology.

N Bowery.   

Abstract

Much progress has been made in GABAB receptor pharmacology since the discovery of this receptor in 1980. Selective agonists and antagonists have been developed and a functional role for the receptor as a mediator of slow inhibitory postsynaptic potentials in many brain regions has emerged. In this article, Norman Bowery discusses the evidence for heterogeneity of GABAB receptors, their possible physiological and pathological roles and the therapeutic potential of GABAB receptor agonists and antagonists.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2559518     DOI: 10.1016/0165-6147(89)90188-0

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  64 in total

1.  The effects of baclofen on calcium channel currents in dorsal sensory cells of the spinal cord in the lamprey.

Authors:  I V Batueva; J T Buchanan; E A Tsvetkov; A K Sagatelyan; N P Veselkin
Journal:  Neurosci Behav Physiol       Date:  1999 Jan-Feb

2.  The human GABA(B1b) and GABA(B2) heterodimeric recombinant receptor shows low sensitivity to phaclofen and saclofen.

Authors:  M D Wood; K L Murkitt; S Q Rice; T Testa; P K Punia; M Stammers; O Jenkins; N A Elshourbagy; U Shabon; S J Taylor; T L Gager; J Minton; W D Hirst; G W Price; M Pangalos
Journal:  Br J Pharmacol       Date:  2000-11       Impact factor: 8.739

3.  Chronic lesion of corticostriatal fibers reduces GABAB but not GABAA binding in rat caudate putamen: an autoradiographic study.

Authors:  R Moratalla; N G Bowery
Journal:  Neurochem Res       Date:  1991-03       Impact factor: 3.996

4.  Effects of pentobarbital tolerance to and dependence on GABAB receptor-binding.

Authors:  T Kimura; P A Saunders; I Yamamoto; I K Ho
Journal:  Neurochem Res       Date:  1991-10       Impact factor: 3.996

5.  The GABAB antagonist, CGP 35348, antagonizes the effects of baclofen, gamma-butyrolactone and HA 966 on rat striatal dopamine synthesis.

Authors:  P C Waldmeier
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-02       Impact factor: 3.000

6.  Phosphinic acid analogues of GABA are antagonists at the GABAB receptor in the rat anococcygeus.

Authors:  J M Hills; A J Sellers; J Mistry; M Broekman; W Howson
Journal:  Br J Pharmacol       Date:  1991-01       Impact factor: 8.739

7.  Evidence for a GABA(B) receptor component in the spinal action of Substance P (SP) on arterial blood pressure in the awake rat.

Authors:  Jonathan Brouillette; Réjean Couture
Journal:  Br J Pharmacol       Date:  2002-08       Impact factor: 8.739

8.  Differential expression of gamma-aminobutyric acid receptor A (GABA(A)) and effects of homocysteine.

Authors:  Neetu Tyagi; David Lominadze; William Gillespie; Karni S Moshal; Utpal Sen; Dorothea S Rosenberger; Mesia Steed; Suresh C Tyagi
Journal:  Clin Chem Lab Med       Date:  2007       Impact factor: 3.694

Review 9.  The diversity of GABAA receptors. Pharmacological and electrophysiological properties of GABAA channel subtypes.

Authors:  W Hevers; H Lüddens
Journal:  Mol Neurobiol       Date:  1998-08       Impact factor: 5.590

10.  Modulation of spontaneous intracellular Ca²⁺ fluctuations and spontaneous cholinergic transmission in rat chromaffin cells in situ by endogenous GABA acting on GABAA receptors.

Authors:  Alejandre-García Tzitzitlini; Segura-Chama Pedro; Pérez-Armendáriz E Martha; Delgado-Lezama Rodolfo; Hernández-Cruz Arturo
Journal:  Pflugers Arch       Date:  2015-10-21       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.